Researchers at the University of Pittsburgh estimate that HCV could become a rare disease as early as 2036, according to a HCP Live report. The researchers based their prediction on the combination of HCV screening at birth and the use of new, direct-acting antiviral drugs.
The number of HCV patients in the United States has already significantly declined. In 2001, there were approximately 3.2 million cases in the country. The number dropped to 2.3 million cases in 2013, according to the report.
More articles on gastroenterology:
HCV outbreak confirmed at Tri-City Colonoscopy Clinic in Canada
Quest Diagnostics, CDC collaborate for hepatitis testing & treatment
3 GI/endoscopy devices receive FDA 510(k) clearance in January
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.